Ionis earnings
Web11 apr. 2024 · Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Equal-Weight and raises the price target from $40 to $42. Web11 apr. 2024 · In the last 3 months, 10 analysts have offered 12-month price targets for Ionis Pharmaceuticals. The company has an average price target of $46.1 with a high of $67.00 and a low of $27.00. Below ...
Ionis earnings
Did you know?
Web9 nov. 2024 · Ionis Pharma Earnings, Revenue Beat in Q3 WebQuarterly Results – Agios Pharmaceuticals, Inc. Quarterly Results Year: 2024 2024 Q4 Q4 2024 Agios Pharmaceuticals Inc Earnings Conference Call Fourth Quarter 2024 Financial Results Presentation Agios Reports Fourth Quarter and Full Year 2024 Financial Results 10-K Annual Report Q3 Q3 2024 Agios Pharmaceuticals Inc Earnings Conference Call
Web4 mei 2024 · Ionis Pharmaceuticals, Inc. (IONS) is scheduled to report first-quarter 2024 … Web8 aug. 2024 · This suggests that analysts have very recently bumped up their estimates for IONS, giving the stock a Zacks Earnings ESP of +27.61% heading into earnings season. Ionis Pharmaceuticals, Inc....
Web13 apr. 2024 · Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) had its price target lifted by investment analysts at Morgan Stanley from $40.00 to $42.00 in a research report issued on Tuesday, Benzinga reports.The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of … Web11 mrt. 2024 · Ionis Pharmaceuticals has a 1 year low of $31.46 and a 1 year high of $48.82. The firm has a market capitalization of $4.97 billion, a price-to-earnings ratio of -18.29 and a beta of 0.57. The company has a debt-to-equity ratio of 2.06, a current ratio of 7.07 and a quick ratio of 7.00.
Web13 apr. 2024 · According to the data, the short interest in Amarin Corporation plc (AMRN) stood at 4.65% of shares outstanding as of Mar 14, 2024; the number of short shares registered in Feb 14, 2024 reached 12.07 million. The stock has risen by 12.40% since the beginning of the year, thereby showing the potential of a further growth.
Web23 feb. 2024 · Ionis total revenues were $587 million in 2024, down 27.5% year over … data center world 2022 parisWeb22 feb. 2024 · As of December 31, 2024, Ionis had cash, cash equivalents and short … datacenter wissousWeb24 feb. 2024 · Ionis Pharmaceuticals (IONS) came out with quarterly earnings of $1.41 … data center world austin txWeb3 nov. 2024 · Ionis' revenue was comprised of the following (amounts in millions): In the … data center world marchWeb1 mei 2024 · We take a look at earnings estimates for some clues. Ionis Pharmaceuticals IONS is scheduled to report first-quarter 2024 results on May 4, before market open. In the last reported quarter, the... bitlocker single fileWeb9 jan. 2024 · NEW YORK and CARLSBAD, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc NASDAQ:RPRX and Ionis Pharmaceuticals, Inc. NASDAQ:IONS today announced that Royalty Pharma has acquired an interest in Ionis’ royalty in Biogen’s SPINRAZA® (nusinersen) and Novartis’ pelacarsen for up to $1.125 bi… datacenter windows server 2016WebFY2026 Earnings Forecast for Ionis Pharmaceuticals, Inc. Issued By SVB Leerink $IONS. 14 Apr 2024 11:25:40 data center world london 2023